BRPI0410710A - composições e métodos que compreendem compostos de gastrina e seus usos - Google Patents
composições e métodos que compreendem compostos de gastrina e seus usosInfo
- Publication number
- BRPI0410710A BRPI0410710A BRPI0410710-1A BRPI0410710A BRPI0410710A BR PI0410710 A BRPI0410710 A BR PI0410710A BR PI0410710 A BRPI0410710 A BR PI0410710A BR PI0410710 A BRPI0410710 A BR PI0410710A
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- methods
- gastrin compounds
- compounds
- beneficial effects
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical class C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 title 1
- 230000009286 beneficial effect Effects 0.000 abstract 2
- 102100021022 Gastrin Human genes 0.000 abstract 1
- 108010052343 Gastrins Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- -1 gastrin compound Chemical class 0.000 abstract 1
- 230000002459 sustained effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2207—Gastrins; Cholecystokinins [CCK]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2003/016660 WO2003100024A2 (en) | 2002-05-24 | 2003-05-27 | Treatment for diabetes |
| PCT/CA2004/000769 WO2004105780A2 (en) | 2003-05-27 | 2004-05-27 | Compositions comprising gastrin compounds and their use in diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0410710A true BRPI0410710A (pt) | 2006-06-13 |
Family
ID=33488788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0410710-1A BRPI0410710A (pt) | 2003-05-27 | 2004-05-27 | composições e métodos que compreendem compostos de gastrina e seus usos |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1648495A2 (https=) |
| JP (1) | JP2007513059A (https=) |
| CN (1) | CN1829528A (https=) |
| AU (1) | AU2004243541A1 (https=) |
| BR (1) | BRPI0410710A (https=) |
| CA (1) | CA2527186A1 (https=) |
| MX (1) | MXPA05012605A (https=) |
| NO (1) | NO20055582L (https=) |
| PL (1) | PL379145A1 (https=) |
| RU (1) | RU2005140518A (https=) |
| WO (1) | WO2004105780A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL156828A0 (en) | 2001-01-12 | 2004-02-08 | Waratah Pharmaceuticals Inc | Prolonged efficacy of islet neogenesis therapy methods with a gastrin/cck receptor ligand and an egf receptor ligand composition in subjects with preexisting diabetes |
| EP1837031B1 (en) | 2002-06-07 | 2009-10-14 | Waratah Pharmaceuticals, Inc. | Compositions and methods for treating diabetes |
| US7560425B2 (en) | 2002-06-07 | 2009-07-14 | Waratah Pharmaceuticals Inc. | Pharmaceutical composition consisting of rapamycine and gastrin 17(LEU15) and a method for treating diabetes |
| US20090202494A1 (en) * | 2004-01-30 | 2009-08-13 | Antonio Cruz | Combined use of glp-1 agonists and gastrin for regulating blood glucose levels |
| WO2008106779A1 (en) * | 2007-03-02 | 2008-09-12 | Waratah Pharmaceuticals Inc. | Gastrin compound for diabetes treatment |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6558952B1 (en) * | 1992-12-14 | 2003-05-06 | Waratah Pharmaceuticals, Inc. | Treatment for diabetes |
| DE69431212T2 (de) * | 1994-01-24 | 2003-04-10 | The General Hospital Corp., Boston | Behandlung von diabetes |
| IL156828A0 (en) * | 2001-01-12 | 2004-02-08 | Waratah Pharmaceuticals Inc | Prolonged efficacy of islet neogenesis therapy methods with a gastrin/cck receptor ligand and an egf receptor ligand composition in subjects with preexisting diabetes |
| KR20050074492A (ko) * | 2002-10-22 | 2005-07-18 | 와라타 파마수티컬즈, 인크. | 당뇨병의 치료 |
-
2004
- 2004-05-27 PL PL379145A patent/PL379145A1/pl not_active Application Discontinuation
- 2004-05-27 MX MXPA05012605A patent/MXPA05012605A/es not_active Application Discontinuation
- 2004-05-27 WO PCT/CA2004/000769 patent/WO2004105780A2/en not_active Ceased
- 2004-05-27 BR BRPI0410710-1A patent/BRPI0410710A/pt not_active IP Right Cessation
- 2004-05-27 EP EP04737749A patent/EP1648495A2/en not_active Withdrawn
- 2004-05-27 CN CNA200480022042XA patent/CN1829528A/zh active Pending
- 2004-05-27 AU AU2004243541A patent/AU2004243541A1/en not_active Withdrawn
- 2004-05-27 CA CA002527186A patent/CA2527186A1/en not_active Abandoned
- 2004-05-27 JP JP2006529497A patent/JP2007513059A/ja active Pending
- 2004-05-27 RU RU2005140518/15A patent/RU2005140518A/ru not_active Application Discontinuation
-
2005
- 2005-11-25 NO NO20055582A patent/NO20055582L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1648495A2 (en) | 2006-04-26 |
| RU2005140518A (ru) | 2007-07-10 |
| WO2004105780A2 (en) | 2004-12-09 |
| AU2004243541A1 (en) | 2004-12-09 |
| CN1829528A (zh) | 2006-09-06 |
| CA2527186A1 (en) | 2004-12-09 |
| JP2007513059A (ja) | 2007-05-24 |
| PL379145A1 (pl) | 2006-07-24 |
| MXPA05012605A (es) | 2006-02-22 |
| NO20055582D0 (no) | 2005-11-25 |
| NO20055582L (no) | 2006-02-27 |
| WO2004105780A3 (en) | 2005-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0307960A (pt) | N-aminoacetil-pirrolidina-2-carbonitrilas e seu uso como inibidores de ddp-iv | |
| BR0316609A (pt) | Sinomenina e compostos de sinomenina, sìntese e uso | |
| BR0316350A (pt) | Diaminotriazóis úteis como inibidores de proteìna cinases | |
| BRPI0412689A (pt) | derivados de heteroarila e arila fundida como moduladores de metabolismo e a profilaxia e tratamento de distúrbios relacionados a ele | |
| BRPI0411862A (pt) | combinações de substáncias ativas com propriedades inseticidas e acaricidas | |
| BR0311222A (pt) | R-enantiÈmeros de derivados de piranoindol contra hepatite c, seu método de obtenção e composição farmacêutica compreendendo os mesmos | |
| ECSP088152A (es) | 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización | |
| BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
| CR20150097A (es) | Composición inmunogénica | |
| BRPI0407139A (pt) | Compostos de amida substituìda por tri(ciclo) | |
| BRPI0513184A (pt) | derivados de 2-carbamida-4-feniltiazol, preparação dos mesmos e aplicação dos mesmos em terapia | |
| BRPI0515316A (pt) | compostos de imidazoquinolina | |
| SV1999000118A (es) | Nuevos derivados de pirazol substituidos ref. lea 33188-sv | |
| ECSP10010735A (es) | Compuestos químicos 251 | |
| BR0312232A (pt) | Inibidores de caspases e seus usos | |
| NO20064186L (no) | Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod | |
| ECSP088252A (es) | 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización | |
| ATE516339T1 (de) | Verwendung von isomeren von bicycloä2.2.1ühept-5- en-2-carbonsäure, ethylester in parfumzusammensetzungen, sowie parfumzusammensetzungen | |
| BRPI0517846A (pt) | azaindolcarboxamidas | |
| DE602004014937D1 (de) | Piperidin-verbindungen als malonyl-coa decarboxylase-hemmer | |
| BRPI0412862A (pt) | derivados da nicotinamida úteis como inibidores de pde4 | |
| BRPI0411087A (pt) | aperfeiçoamentos em ou relacionados a compostos orgánicos | |
| BRPI0410710A (pt) | composições e métodos que compreendem compostos de gastrina e seus usos | |
| BR0208131A (pt) | Derivados biguanida | |
| SE0004101D0 (sv) | New use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES. |
|
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |